Roby Joyce serves as Executive at bioAffinity Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Roby Joyce has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 1, 2024 involved receiving (via award) 33,784 shares valued at $0.
Roby Joyce currently holds 66,615 shares of bioAffinity Technologies, Inc. (BIAF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roby Joyce has been a net neutral trader of BIAF stock. They have purchased $0 and sold $0 worth of shares.
Roby Joyce's most recent insider trade was on Jul 1, 2024, when they sold 33,784 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |